Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RBMS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBASH3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EXTL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRAT13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HNRNPR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSUN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSM14B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JUND - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on